ニューヨークにおける潰瘍性大腸炎の臨床試験
ニューヨーク内の拠点で、潰瘍性大腸炎に関する31件の研究が参加者を募集しています。
ニューヨーク内の都市
公式研究テキスト（英語）
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- New York Gastroenterology Associates - Upper East Side /ID# 281767, New York
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/10/01更新 · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Westchester Putnam Gastroenterology PC, Carmel
- Five Towns Gastroenterology, Cedarhurst
- IMIDeology, Elmhurst
- 他5件
被験者募集中第4相
18歳〜80歳 · 全性別 · 2026/09/30更新 · NCT06581328A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
- Ellipsis Research Group, Brooklyn
- Smart Medical Research - Jackson Heights, Jackson Heights
- Pioneer Clinical Research NY, New York
- 他1件
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/30更新 · NCT06598943Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
- Xencor Investigative Site, Albany
- Xencor Investigative Site, Rochester
被験者募集中第1/2相健康なボランティア歓迎
18歳〜75歳 · 全性別 · 2026/09/29更新 · NCT06619990A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Site 037, New York
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/29更新 · NCT07012395A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
- Site US-002, Albany
- Site US-016, Rochester
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/29更新 · NCT07845487A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
- Intercity Gastroenterology, Fresh Meadows
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/28更新 · NCT06979336A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
- Westchester Putnam Gastroenterology, Carmel
- Inflammatory Bowel Disease Center at NYU Langone, New York
- Icahn School of Medicine at Mount Sinai, New York
- 他3件
被験者募集中第3相
12歳以上 · 全性別 · 2026/09/25更新 · NCT07196748A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
- Columbia University Medical Center, New York
被験者募集中第2/3相
2歳〜17歳 · 全性別 · 2026/09/24更新 · NCT05076175Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Icahn School of Medicine at Mount Sinai, New York
- New York Gastroenterology Associates, New York
- Care Access - Yonkers, Yonkers
被験者募集中第3相
18歳〜70歳 · 全性別 · 2026/09/24更新 · NCT06937086Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- NYU Langone Hospital - Long Island, Mineola
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- 他1件
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/23更新 · NCT03816345A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- Icahn School of Medicine at Mount Sinai, New York
被験者募集中第3相
2歳〜19歳 · 全性別 · 2026/09/22更新 · NCT04844606LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
- Digestive Disease Medicine of Central New York, Utica
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/09/22更新 · NCT07186101LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- Stony Brook University, Stony Brook
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/09/22更新 · NCT07415044A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
- NYU Langone Health, New York
- Weill Cornell Medical College- New York Presbyterian Hospital, New York
被験者募集中第4相
18歳〜65歳 · 全性別 · 2026/09/21更新 · NCT06095128A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- MedTraits NY - Site Number: 8400045, Maspeth
- Weill Cornell Medicine - NewYork-Presbyterian Hospital - Site Number: 8400040, New York
- New York Gastroenterology Associates - Site Number: 8400009, New York
被験者募集中第3相
16歳〜80歳 · 全性別 · 2026/09/15更新 · NCT07185009Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
- New York Gastroenterology Associates ( Site 0253), New York
被験者募集中第3相
全年齢 · 全性別 · 2026/09/09更新 · NCT06651281A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
- New York Gastroenterology Associates, New York
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/28更新 · NCT07577856A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis
- Fink Children's Ambulatory Care Center, New York
- Kimmel Pavilion - NYU Langone, New York
- NYU Grossman School of Medicine, New York
- 他4件
被験者募集中第2相
2歳〜11歳 · 全性別 · 2026/08/24更新 · NCT07470879A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
- Columbia University Medical Center, New York
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/08/21更新 · NCT06636656An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- MedTraits NY - Site Number: 8400045, Maspeth
- Manhattan Clinical Research, LLC - Site Number: 8400069, New York
- NYU Langone Health - Site Number: 8400091, New York
- 他4件
被験者募集中第3相
16歳〜80歳 · 全性別 · 2026/08/20更新 · NCT07184996Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
- Saratoga Schenectady Gastroenterology Associates, Burnt Hills
- NYU Langone Health, New York
- Cornell University, New York
被験者募集中
18歳以上 · 全性別 · 2026/08/07更新 · NCT05230173BOOM-IBD2 Pivotal Clinical Trial
- Northwell Health North Shore University Hospital, Manhasset
- Columbia University Irving Medical Center/New York Presbyterian Hospital, New York
被験者募集中
18歳〜85歳 · 全性別 · 2026/08/06更新 · NCT06571669Zymfentra (Infliximab-dyyb) REal World Cohort STudy
- New York University, New York
被験者募集中観察研究
18歳以上 · 全性別 · 2026/08/05更新 · NCT07237516An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
- NYU Langone Health, New York
- Lenox Hill Hospital, Northwell Health, New York
被験者募集中観察研究
18歳〜64歳 · 全性別 · 2026/07/09更新 · NCT06398626A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- New York Presbyterian Hospital, New York
被験者募集中第3相
2歳〜17歳 · 全性別 · 2026/06/22更新 · NCT06405087A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis
- Investigational Site Number: 8400021, New York
- Investigational Site Number: 8400029, Queens Village
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/04/23更新 · NCT06975722A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, New York
- Mirador Therapeutics Selected Site, Rochester
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/03/12更新 · NCT07113522Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)
- State University of New York Upstate Medical University, Syracuse
被験者募集中
18歳〜85歳 · 全性別 · 2026/01/08更新 · NCT05987852Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis
- Bausch Health Site 006, The Bronx
被験者募集中第4相
5歳〜17歳 · 全性別 · 2025/09/16更新 · NCT04314375Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention
- New York University, New York
被験者募集中観察研究
18歳以上 · 全性別 · 2025/05/08更新 · NCT06750731ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。